Trial Details
Not RecruitingBasic Information
| Clinical ID | c2976 |
|---|---|
| Identifier | EUCTR2015-002109-12-LV |
| Trial Title | An Extension Study of APD334-003 in Patients with Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Ulcerative colitis MedDRA version: 19.0_Level: LLT_Classification code 10045365_Term: Ulcerative colitis_System Organ Class: 100000004856_;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Product Name: APD334 Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Not yet available Other descriptive name: APD334 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 2- Pharmaceutical form of the placebo: Tablet Route of administration of the placebo: Oral use |
Participant Information
| Sponsor | Arena Pharmaceuticals, Inc. |
|---|---|
| City | - |
| Country/Region | United States;Spain;Ukraine;Lithuania;Austria;Russia;Israel;United Kingdom;France;Czech Republic;Hungary;Canada;Poland;Belgium;Romania;Australia;Bulgaria;Latvia;Germany;New Zealand |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |